患者与员工对医院减害服务影响与挑战的看法
这项定性研究于2022年10月至2023年3月在加州一家城市安全网医院对20例住院患者和20名员工进行40分钟半结构访谈,采用主题分析。识别出3个主题:减害项目扩大减害教育及用品可及性(尤其对少数族裔)、通过改善患者体验和增加参与建立信任、通过帮助去污名化并提升员工成就感催化文化变革。项目挑战包括对法规的犹豫、员工物质使用障碍教育有限、残留污名以及需仔细评估患者目标。作者认为将减害服务整合到医院护理可增加不熟悉减害人群的可及性、改善信任并减少污名。
要点
- 患者和员工报告减害项目扩大了减害教育及用品(如注射器、吸管、纳洛酮和检测试纸)的可及性,尤其对少数族裔人群。
- 黑人和拉丁裔患者、主要使用兴奋剂者以及英语水平有限(LEP)的患者报告学到了新的减害策略。
- 减害项目通过改善患者护理体验和增加参与来建立信任,并帮助去污名化、提升员工成就感。
- 项目挑战包括对法规的犹豫、员工物质使用障碍教育有限、残留污名以及需仔细评估患者目标。
- 作者认为尤其需要努力增加黑人和拉丁裔及LEP人群(包括使用兴奋剂者)获得减害服务的机会。
适用人群与场景
- 住院患者,接受减害服务(来自成瘾咨询团队的减害教育和/或用品,如注射器、吸管、纳洛酮和检测试纸),或为接受这些服务的患者提供护理的医院员工。
- 研究在一家城市安全网医院进行,地点为加利福尼亚,时间为2022年10月至2023年3月。
研究设计与关键结果
- 定性研究,共40名参与者完成访谈,包括20例患者(平均[SD]年龄43[13]岁;1名美洲印第安人或阿拉斯加原住民[5%],1名亚洲和太平洋岛民[5%],6名黑人[30%];6名拉丁裔[30%];6名白人[30%])和20名员工(平均[SD]年龄37[8]岁)。
- 患者诊断为多种物质使用障碍(7例阿片和兴奋剂使用障碍[35%];7例兴奋剂使用障碍[35%];3例阿片使用障碍[15%];3例酒精使用障碍[15%])。
- 识别出3个主题:减害项目(1)扩大减害教育及用品可及性,尤其对少数族裔人群;(2)通过改善患者护理体验和增加参与建立信任;(3)通过帮助去污名化计划继续使用物质个体的护理并提升员工成就感来催化文化变革。
- 黑人和拉丁裔患者、主要使用兴奋剂者以及英语水平有限(LEP)的患者报告学到了新的减害策略。
- 项目挑战包括对法规的犹豫、员工物质使用障碍教育有限、残留污名以及需仔细评估患者目标。
证据类型、等级与局限
- 定性研究(半结构访谈),采用主题分析。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,将减害服务整合到医院护理可增加不熟悉减害人群的可及性、改善信任并减少污名。
- 作者认为,尤其需要努力增加黑人和拉丁裔及LEP人群(包括使用兴奋剂者)获得减害服务的机会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Harm reduction is associated with improved health outcomes among people who use substances. As overdose deaths persist, hospitals are recognizing the need for harm reduction services; however, little is known about the outcomes of hospital-based harm reduction for patients and staff.
OBJECTIVE: To evaluate patient and staff perspectives on the impact and challenges of a hospital-based harm reduction program offering safer use education and supplies at discharge.
DESIGN, SETTING, AND PARTICIPANTS: This qualitative study consisted of 40-minute semistructured interviews with hospitalized patients receiving harm reduction services and hospital staff at an urban, safety-net hospital in California from October 2022 to March 2023. Purposive sampling allowed inclusion of diverse patient racial and ethnic identities, substance use disorders (SUDs), and staff roles.
EXPOSURE: Receipt of harm reduction education and/or supplies (eg, syringes, pipes, naloxone, and test strips) from an addiction consult team, or providing care for patients receiving these services.
MAIN OUTCOMES AND MEASURES: Interviews were analyzed using thematic analysis to identify key themes.
RESULTS: A total of 40 participants completed interviews, including 20 patients (mean [SD] age, 43 [13] years; 1 American Indian or Alaska Native [5%], 1 Asian and Pacific Islander [5%], 6 Black [30%]; 6 Latine [30%]; and 6 White [30%]) and 20 staff (mean [SD] age 37 [8] years). Patients were diagnosed with a variety of SUDs (7 patients with opioid and stimulant use disorder [35%]; 7 patients with stimulant use disorder [35%]; 3 patients with opioid use disorder [15%]; and 3 patients with alcohol use disorder [15%]). A total of 3 themes were identified; respondents reported that harm reduction programs (1) expanded access to harm reduction education and supplies, particularly for ethnically and racially minoritized populations; (2) built trust by improving the patient care experience and increasing engagement; and (3) catalyzed culture change by helping destigmatize care for individuals who planned to continue using substances and increasing staff fulfillment. Black and Latine patients, those who primarily used stimulants, and those with limited English proficiency (LEP) reported learning new harm reduction strategies. Program challenges included hesitancy regarding regulations, limited SUD education among staff, remaining stigma, and the need for careful assessment of patient goals.
CONCLUSIONS AND RELEVANCE: In this qualitative study, patients and staff believed that integrating harm reduction services into hospital care increased access for populations unfamiliar with harm reduction, improved trust, and reduced stigma. These findings suggest that efforts to increase access to harm reduction services for Black, Latine, and LEP populations, including those who use stimulants, are especially needed.
参考来源
- Fraimow-Wong L, Martín M, Thomas L, et al. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction. JAMA Netw Open. 2024. PMID: 38386317. doi:10.1001/jamanetworkopen.2024.0229
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。